House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention
In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office
NCI Announces Designation Of Comprehensive Center
Columbus CCP Forms New Entity to Administer CCOP
Garfinkel to Retire From ACS; Health to Succeed Him
Fox Chase Biochemist Automates DNA Production
Broder Explains Where R01 Money Has Gone
AACR Honorary Memberships; ASCO Awards
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - George Sigounas named the first-ever chief science advisor at NCI
- In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response